Hisamitsu Pharmaceutical Valuation
| HPX Stock | EUR 24.80 0.40 1.59% |
At this time, the firm appears to be overvalued. Hisamitsu Pharmaceutical retains a regular Real Value of €21.04 per share. The prevalent price of the firm is €24.8. Our model calculates the value of Hisamitsu Pharmaceutical from evaluating the firm fundamentals such as Return On Asset of 0.0212, current valuation of 1.09 B, and Return On Equity of 0.0504 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Hisamitsu Pharmaceutical's price fluctuation is not too volatile at this time. Calculation of the real value of Hisamitsu Pharmaceutical is based on 3 months time horizon. Increasing Hisamitsu Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hisamitsu stock is determined by what a typical buyer is willing to pay for full or partial control of Hisamitsu Pharmaceutical Co. Since Hisamitsu Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hisamitsu Stock. However, Hisamitsu Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.8 | Real 21.04 | Hype 24.8 |
The real value of Hisamitsu Stock, also known as its intrinsic value, is the underlying worth of Hisamitsu Pharmaceutical Company, which is reflected in its stock price. It is based on Hisamitsu Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hisamitsu Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hisamitsu Pharmaceutical Co helps investors to forecast how Hisamitsu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hisamitsu Pharmaceutical more accurately as focusing exclusively on Hisamitsu Pharmaceutical's fundamentals will not take into account other important factors: Hisamitsu Pharmaceutical Total Value Analysis
Hisamitsu Pharmaceutical Co is currently estimated to have takeover price of 1.09 B with market capitalization of 2.02 B, debt of 219 M, and cash on hands of 143.16 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hisamitsu Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.09 B | 2.02 B | 219 M | 143.16 B |
Hisamitsu Pharmaceutical Investor Information
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hisamitsu Pharmaceutical last dividend was issued on the 27th of February 2023. The entity had 2:1 split on the 27th of June 2000. Hisamitsu Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Hisamitsu Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hisamitsu Pharmaceutical has an asset utilization ratio of 39.69 percent. This implies that the Company is making €0.4 for each dollar of assets. An increasing asset utilization means that Hisamitsu Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Hisamitsu Pharmaceutical Ownership Allocation
Hisamitsu Pharmaceutical Co has a total of 79.53 Million outstanding shares. Hisamitsu Pharmaceutical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hisamitsu Pharmaceutical Profitability Analysis
The company reported the revenue of 120.19 B. Net Income was 9.66 B with profit before overhead, payroll, taxes, and interest of 70.07 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hisamitsu Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hisamitsu Pharmaceutical and how it compares across the competition.
About Hisamitsu Pharmaceutical Valuation
The stock valuation mechanism determines Hisamitsu Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Hisamitsu Pharmaceutical. We calculate exposure to Hisamitsu Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hisamitsu Pharmaceutical's related companies.Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.
8 Steps to conduct Hisamitsu Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Hisamitsu Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Hisamitsu Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Hisamitsu Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Hisamitsu Pharmaceutical's revenue streams: Identify Hisamitsu Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Hisamitsu Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Hisamitsu Pharmaceutical's growth potential: Evaluate Hisamitsu Pharmaceutical's management, business model, and growth potential.
- Determine Hisamitsu Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Hisamitsu Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Hisamitsu Stock analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |